Kairos Pharma（KAPA.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

© 2026 Longbridge｜服务条款隐私政策

股东类型

公众及其他58.44%
个人与内部人士28.77%
机构投资者7.82%
私营企业4.97%

主要股东

主要股东最新
股东
John YuCEO, Chairman & Secretary	22.58%	535.12 万	2.41%	+0	2025/10/08
Technomedics Management & Systems, Inc	4.95%	117.36 万	0.53%	+0	2025/07/28
Neil BhowmickChief Scientific Officer	4.79%	113.53 万	0.51%	+0	2025/10/08
Armistice Capital LLC	3.73%	88.49 万	0.40%	+0	2025/06/30
Citadel Advisors LLC	1.31%	30.98 万	1.31%	+30.98 万	2026/06/30
Vanguard Capital Management, LLC	1.25%	29.58 万	0.13%	+0	2026/06/30
Ramachandran MuraliVice President of Research & Development	0.60%	14.22 万	0.06%	+0	2025/10/08
Douglas SamuelsonChief Financial Officer	0.59%	14.04 万	0.06%	+0	2025/10/08
Virtu Financial, Inc.	0.35%	8.21 万	0.35%	+8.21 万	2026/06/30
Geode Capital Management, LLC	0.33%	7.89 万	0.19%	-3.24 万	2026/06/30
Hyun BaeIndependent Director	0.20%	4.76 万	0.02%	+0	2025/10/08
SevenBridge Financial Group, LLC	0.19%	4.43 万	0.02%	+0	2026/06/30
Aptus Capital Advisors, LLC	0.19%	4.43 万	0.02%	+0	2026/06/30
Jane Street Group, LLC	0.14%	3.37 万	--	+3.37 万	2026/06/30
Susquehanna International Group, LLP	0.12%	2.93 万	--	+2.93 万	2026/06/30
State Street Investment Management	0.10%	2.41 万	0.01%	+0	2026/06/30
XTX Markets Limited	0.06%	1.49 万	0.06%	+1.49 万	2026/06/30
UBS Asset Management AG	0.03%	6,261.00	0.03%	+6,261.00	2026/06/30
Tower Research Capital Europe Limited	0.02%	3,733.00	<0.01%	-229.00	2026/06/30
Hansoo Michael KeyoungIndependent Director	0.01%	3,334.00	<0.01%	+0	2025/10/08